DE69003804T2 - Fentanyl enthaltende aerosolzubereitungen. - Google Patents

Fentanyl enthaltende aerosolzubereitungen.

Info

Publication number
DE69003804T2
DE69003804T2 DE90901641T DE69003804T DE69003804T2 DE 69003804 T2 DE69003804 T2 DE 69003804T2 DE 90901641 T DE90901641 T DE 90901641T DE 69003804 T DE69003804 T DE 69003804T DE 69003804 T2 DE69003804 T2 DE 69003804T2
Authority
DE
Germany
Prior art keywords
aerosol preparations
containing aerosol
fentanyl containing
fentanyl
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90901641T
Other languages
English (en)
Other versions
DE69003804D1 (de
Inventor
Tarlochan Purewal
Anthony Wilkinson
Alison Lambert
David Smith
David Highthorne Cotta Donnell
Anton Kuepper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of DE69003804D1 publication Critical patent/DE69003804D1/de
Publication of DE69003804T2 publication Critical patent/DE69003804T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
DE90901641T 1989-01-06 1990-01-04 Fentanyl enthaltende aerosolzubereitungen. Expired - Fee Related DE69003804T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900267A GB8900267D0 (en) 1989-01-06 1989-01-06 Narcotic analgesic formulations and apparatus containing same
PCT/GB1990/000015 WO1990007333A1 (en) 1989-01-06 1990-01-04 Fentanyl containing aerosol compositions

Publications (2)

Publication Number Publication Date
DE69003804D1 DE69003804D1 (de) 1993-11-11
DE69003804T2 true DE69003804T2 (de) 1994-05-05

Family

ID=10649685

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90901641T Expired - Fee Related DE69003804T2 (de) 1989-01-06 1990-01-04 Fentanyl enthaltende aerosolzubereitungen.

Country Status (7)

Country Link
EP (1) EP0452384B1 (de)
JP (1) JPH04504566A (de)
CA (1) CA2058428C (de)
DE (1) DE69003804T2 (de)
GB (1) GB8900267D0 (de)
NZ (1) NZ232020A (de)
WO (1) WO1990007333A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
EP0965335B1 (de) * 1990-03-23 2003-09-17 Minnesota Mining And Manufacturing Company Aerosolzubereitungen zur dosierten Abgabe
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
US5474759A (en) * 1991-06-10 1995-12-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
CZ271393A3 (en) * 1991-06-10 1994-07-13 Schering Corp Aerosol preparations without chlorofluorinated hydrocarbons
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
DK0616524T3 (da) * 1991-12-12 1999-06-21 Glaxo Group Ltd Lægemidler
WO1993011745A1 (en) * 1991-12-12 1993-06-24 Glaxo Group Limited Medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
EP0673240B1 (de) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilisierte medizinische aerosollösungen
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5934272A (en) * 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
ES2154673T3 (es) * 1993-01-29 2001-04-16 Aradigm Corp Suministro intrapulmonar de hormonas.
US5558085A (en) * 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
WO1994022422A1 (en) * 1993-03-29 1994-10-13 Henry Richard A Lidocaine aerosol anaesthetic
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
WO1995031182A1 (en) * 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
WO2001068140A2 (en) * 2000-03-10 2001-09-20 Durect Corporation Opioid formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7074803B2 (en) 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
WO2001097780A2 (en) * 2000-06-22 2001-12-27 Pharmasol Ltd Pharmaceutical compositions comprising an opioid analgesic
EE05420B1 (et) 2000-07-31 2011-06-15 Nycomed Danmark A/S Fentanli kompositsioon ninasiseseks manustamiseks
AU2002230993B2 (en) 2000-12-29 2006-02-02 Alkermes, Inc. Particles for inhalation having sustained release properties
EP1392262A1 (de) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Verabreichung von arzneimittel-estern durch inhalation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
DE10130449A1 (de) * 2001-06-23 2003-01-09 Martin Schmidt Inhalierbare Sedativa und Hypnotika für den medizinischen Gebrauch
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
AU2002361742A1 (en) * 2001-12-18 2003-06-30 Alexza Molecular Delivery Corporation Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US7648982B2 (en) 2003-02-28 2010-01-19 Ym Biosciences Inc. Opioid delivery system
US7648981B2 (en) 2003-02-28 2010-01-19 Ym Biosciences Inc. Opioid delivery system
AU2004316339A1 (en) * 2003-02-28 2005-09-09 Ym Biosciences Inc. Opioid delivery system
BRPI0408059A (pt) * 2003-02-28 2006-02-14 Delex Therapeutics Inc sistema de administração de opióides
WO2004104491A2 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
AU2007208229B2 (en) 2006-01-25 2009-11-05 Insys Therapeutics Inc. Sublingual fentanyl spray
KR20090129998A (ko) 2007-02-11 2009-12-17 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법
EP1964564A1 (de) * 2007-04-19 2008-09-03 LAB International SRL Durchbruchsschmerzbehandlung
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
AU2008282743B2 (en) 2007-08-02 2012-11-29 Insys Therapeutics Inc. Sublingual fentanyl spray

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602370A1 (de) * 1986-01-27 1987-08-06 Chrubasik Sigrun Verwendung von analgetica durch inhalation

Also Published As

Publication number Publication date
CA2058428A1 (en) 1990-07-07
JPH04504566A (ja) 1992-08-13
GB8900267D0 (en) 1989-03-08
NZ232020A (en) 1992-03-26
EP0452384B1 (de) 1993-10-06
CA2058428C (en) 2000-09-05
DE69003804D1 (de) 1993-11-11
EP0452384A1 (de) 1991-10-23
WO1990007333A1 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
DE69003804D1 (de) Fentanyl enthaltende aerosolzubereitungen.
DE68913693T2 (de) Aerosol-Zusammensetzung.
NO871709D0 (no) Aerosoldispenser.
ATE373465T1 (de) Aerosolzubereitungen
ATA165489A (de) Nitroglycerinhaltige spray-präparate
FI880107A (fi) Doseringsanordning foer aerosol.
FI895713A0 (fi) Aerosol avgivande artikel.
BR8806604A (pt) Aerossol de inseticida
NO890453D0 (no) Artropodicide preparater.
DK624787D0 (da) Aerosolventil
DK151490D0 (da) Aerosoldispenser
BR8806603A (pt) Aerossol de inseticida
NO885709D0 (no) Aerosoldispenser.
NO894895L (no) Flammehemmende preparater.
DE68905149D1 (de) Insekticides aerosol.
DE69005526D1 (de) Aerosolbehälter.
DE68912215D1 (de) Aerosolzusammensetzung.
NO911243L (no) Kjemiske preparater.
ATE95420T1 (de) Fentanyl enthaltende aerosolzubereitungen.
DK300189D0 (da) Aerosolbeholder
NO913298D0 (no) Terapeutisk aerosolpreparater.
ATE102641T1 (de) Aerosol-zusammensetzung.
NO883492L (no) Organopolysiloksanholdige belegningspreparater.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee